Zoetis marked the completion of a 19,000-square-foot, three-story expansion at its manufacturing facility last week in Lincoln, Neb., with a ribbon-cutting ceremony attended by Lincoln Mayor Chris Beutler.

Through increased production at the facility, Zoetis is affirming its position as a global leader and world-class manufacturer of high-quality animal health products and an employer of choice in Lincoln, the company said in a news release.

“Zoetis is excited to expand its footprint in Lincoln and provide veterinarians, livestock producers, pet owners and the animals in their care with a reliable, consistent supply of quality animal health products,” Betty Mason, site leader in Lincoln, said. “The entire community can be proud of our expanded manufacturing operations, which enable us to produce 1,200 finished goods for more than 100 markets around the world.”

The site is one of the largest internal manufacturing operations within Zoetis, employing approximately 500 people. With the expansion, as many as 30 new positions could be added at peak production time. Zoetis produces some of its flagship pharmaceutical products and vaccines at the Lincoln plant, including BOVI-SHIELD GOLD® and RESPISURE ONE® for livestock and RIMADYL® (carprofen) for dogs. The expansion will also facilitate the full production of SYNOVEX®, a product that helps increase weight gain and improve feed efficiency in beef cattle.